Loading...

ALK-Abelló A/S

AKBLFPNK
Healthcare
Biotechnology
$30.44
$0.00(0.00%)

ALK-Abelló A/S (AKBLF) Stock Overview

Explore ALK-Abelló A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 74.0/100

Key Financials

Market Cap6.8B
P/E Ratio45.68
EPS (TTM)$0.65
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 Months$29.31
1 Year Target$28.50

AKBLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ALK-Abelló A/S (AKBLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $28.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 45.68 and a market capitalization of 6.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;